Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Pfizer's stock decline due to COVID normalization presents opportunity for investors, with potential growth and dividend yield in 2024. Learn more on PFE stock here.

Recent health news highlights various developments, including Trump's spending bill impacting insurance costs, a major acquisition in the bioscience sector, and GSK's efforts to expand RSV vaccine ...

Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point. Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted.

Where you’re born — or to whom you’re born — should not determine your health outcomes. But, for many people across the U.S. and around the globe, it does, said Pfizer’s vice president ...

To help close this health equity gap, in May 2022 with African leaders from Rwanda, Ghana, Senegal and Malawi, Pfizer launched An Accord for a Healthier World (the Accord)—an initiative that is ...

With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, and markets innovative medicines and vaccines across diverse ...

Last month, news broke that Pfizer Inc. wanted to take over AstraZeneca. AstraZeneca has been fighting those advances. The standoff speaks to the changes taking place in the pharmaceutical sector.

Researchers looked at health information for over 300 patients. Forshee suggested a similar change for Pfizer’s Comirnaty vaccine, which was approved in August 2021.

Starboard Value is knocking on Pfizer’sPFE-2.92%decrease; red down pointing triangle door, demanding the drugmaker make changes to improve performance. The problem for the company and its new ...

Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted. Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point.